日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sotagliflozin Enhances Left Ventricular Function and Myocardial Perfusion in Chronic Myocardial Ischemia Through Metabolic and Redox Remodeling

索格列净通过代谢和氧化还原重塑增强慢性心肌缺血患者的左心室功能和心肌灌注

Muir, Kelsey C; Stone, Christopher; Reddy, Riya; Kanuparthy, Meghamsh; Hamze, Jad; Harris, Dwight D; Abid, M Ruhul; Sellke, Frank W

Extracellular Vesicles as Biomarkers and Non-Surgical Therapeutics in Cardiovascular Diseases

细胞外囊泡作为心血管疾病的生物标志物和非手术治疗方法

Almazroua, Dana A; Muir, Kelsey C; Abid, M Ruhul

Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease

在冠状动脉疾病的大动物模型中,司美格鲁肽可改善心肌灌注和功能

Stone, Christopher; Harris, Dwight D; Broadwin, Mark; Kanuparthy, Meghamsh; Nho, Ju-Woo; Yalamanchili, Keertana; Hamze, Jad; Abid, M Ruhul; Sellke, Frank W

Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome

在代谢综合征猪模型中,SGLT-2抑制剂卡格列净可改善心肌功能和血管生成,且这种改善具有性别特异性。

Harris, Dwight D; Broadwin, Mark; Stone, Christopher; Sabe, Sharif A; Kanuparthy, Meghamsh; Nho, Ju-Woo; Muir, Kelsey C; Abid, M Ruhul; Sellke, Frank W

Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia

二肽基肽酶-4抑制剂利格列汀可改善慢性心肌缺血大动物模型中的纤维化、细胞凋亡和心脏功能。

Harris, Dwight Douglas 2nd; Stone, Christopher; Broadwin, Mark; Kanuparthy, Meghamsh; Sabe, Sharif A; Nho, Ju-Woo; Hamze, Jad; Abid, M Ruhul; Sellke, Frank W

Female patients exhibit altered vasopressin-induced coronary microvascular contractile response and molecular signaling following cardiac surgery.

女性患者在心脏手术后表现出血管加压素诱导的冠状动脉微血管收缩反应和分子信号传导的改变

Banerjee Debolina, Sabe Sharif A, Sodha Neel R, Ehsan Afshin, Cioffi William G, Miner Thomas J, Li Janelle, Abid M Ruhul, Feng Jun, Sellke Frank W

Mitochondria-targeted ROS scavenger JP4-039 improves cardiac function in a post-myocardial infarction animal model and induces angiogenesis in vitro.

线粒体靶向 ROS 清除剂 JP4-039 可改善心肌梗死后动物模型的心脏功能,并在体外诱导血管生成

Teixeira Rayane Brinck, Albro Jane H, Sabra Mohamed, Abedin Taslova, Tucker Aja N, Sidharth Raj, Sellke Frank W, Wipf Peter, Abid M Ruhul

Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease: A Review of Current Strategies, Methodologies and Future Directions

基于细胞外基质的血管生成疗法在缺血性心脏病治疗中的进展:当前策略、方法和未来方向综述

Hamze, Jad; Broadwin, Mark; Stone, Christopher; Muir, Kelsey C; Sellke, Frank W; Abid, M Ruhul

Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemia

实验室培育的3D细胞外基质颗粒可改善心肌缺血时的心脏功能和形态

Broadwin, Mark; St Angelo, Katerina; Petersen, Max; Teixeira, Rayane B; Harris, Dwight D; Stone, Christopher R; Xu, Cynthia; Kanuparthy, Meghamsh; Sellke, Frank W; Morgan, Jeffrey; Abid, M Ruhul

Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic

靶向线粒体活性氧:JP4-039作为心血管治疗药物的潜力

Yalamanchili, Keertana; Broadwin, Mark; Harris, Dwight D; Teixeira, Rayane B; Sellke, Frank W; Wipf, Peter; Abid, M Ruhul